Meet the Evolving CPL at CPHI Milan: More Capabilities, More Expertise, More Reasons to Talk
By Kyle Loethen
Meet the Evolving CPL at CPHI Milan: More Capabilities, More Expertise, More Reasons to Talk
Seven Important Questions Every Pharmaceutical Company Should Ask Before Choosing a CDMO
By Kyle Loethen
Testosterone Manufacturing Is Not the Place to Experiment: Why Experience Matters When Choosing a CDMO
By Kyle Loethen
The Hidden Reasons CDMO Projects Go Off Track Before Manufacturing Ever Begins
By Kyle Loethen
Meet CPL at the Rutgers Annual Innovations in Dermatological Sciences Conference: Why Commercial Thinking Matters in Topical Drug Development
By Kyle Loethen
Bridging the Hidden Gap: Why Sponsors Need a Guided Handoff from Development to Manufacturing
By Kyle Loethen
Heading to Contract Pharma 2026? The Questions Every Pharmaceutical Company Should Ask Its Next CDMO
By Kyle Loethen
You’re Not Hiring a Vendor. You’re Entrusting Your Company’s Future. At CPL, We Understand That.
By Kyle Loethen
Why CPL Is Built for Complex Topical Reformulation Programs
By Kyle Loethen
How CPL Approaches Reformulation for Underperforming Topical Products
By Kyle Loethen